Aclaris Therapeutics reported early study results showing its ATI-2138 drug drove rapid and lasting hair regrowth, ...
ATI-2138 Outperforms Ritlecitinib in Reversal Model of Alopecia Universalis, the Most Severe AA Phenotype - WAYNE, Pa., Jan.
A research team led by Professor Tae-Gyu Lim from the Department of Food Science and Biotechnology at Sejong University has ...
For decades, baldness treatments have inched forward with incremental gains and frustrating side effects. Now a simple gel ...